Kyowa Kirin Co., Ltd.
Kyowa Kirin Co., Ltd. (JPX: 4151) is trading at ¥2,267.00, about ₹1,380 at today's JPY/INR rate, as of 25 Sep 2026, 2:30 AM ET, up 0.24% today. Indian residents can buy Kyowa Kirin from India on Paasa under the RBI's Liberalised Remittance Scheme.
Quote
Today's low
¥2,251.00
Today's high
¥2,286.50
52 week low
¥2,109.00
52 week high
¥2,912.00
4151 opened at ¥2,255.00, closed previously at ¥2,261.50, and has traded between ¥2,109.00 and ¥2,912.00 over the past 52 weeks.
About
Operating globally, Kyowa Kirin Co., Ltd. is a pharmaceutical company focused on the discovery, development, manufacturing, and marketing of innovative medical therapies. The company's core areas of expertise span oncology, nephrology, central nervous system disorders, and immunology. Its extensive product portfolio includes established medications such as ABSTRAL, a sublingual fentanyl formulation for managing breakthrough pain in cancer patients; ALLELOCK, an antihistamine for various allergic conditions; and CONIEL, a calcium channel blocker prescribed for hypertension and angina. Kyowa Kirin also provides a range of advanced biological and specialized treatments. These encompass Crysvita, a recombinant human monoclonal IgG1 antibody targeting fibroblast growth factor 23, and blood-related therapies like ESPO (human erythropoietin), NESP (an erythropoiesis stimulating agent), and GRAN (a human colony-stimulating factor). Further products in its lineup address diverse medical needs: G-LASTA/Peglasta/Neulasta for chemotherapy-induced febrile neutropenia; LEUNASE for acute lymphoblastic leukemia; LUMICEF, a biological treatment for moderate to severe plaque psoriasis; Moventig, a mu-opioid receptor antagonist for opioid-induced constipation; Nouriast/Nourianz, an adenosine receptor antagonist for Parkinson's disease; and ORKEDIA, an oral calcimimetics agent. Other significant offerings are PecFent, a nasally administered spray; POTELIGEO, a humanized monoclonal antibody targeting CC chemokine receptor 4; REGPARA for secondary hyperparathyroidism; Romiplate/Nplate, a recombinant protein promoting platelet production; and SANCUSO for managing nausea and vomiting. Beyond its current offerings, Kyowa Kirin is actively involved in pipeline development, notably through a strategic collaboration with Amgen Inc. for the joint development and commercialization of KHK4083. This Phase 3-ready, fully human anti-OX40 monoclonal antibody is being developed to treat atopic dermatitis. Established in Tokyo, Japan, in 1949, the company changed its name from Kyowa Hakko Kirin Co., Ltd. to Kyowa Kirin Co., Ltd. in June 2019. It operates as a subsidiary of Kirin Holdings Company, Limited.
Key statistics
Avg. volume
1.42M
Market cap
¥1.19T
P/E Ratio
14.59
Price-to-sales ratio
2.24
Enterprise value
¥943.86B
Free cash flow yield
8.66%
Debt-to-equity ratio
0.02
Return on equity
9.17%
ROIC
10.79%
Beta
0.73
Dividend yield
2.96%
Last dividend
¥67.00
Financial overview
Revenue
¥496.83B
Earnings per share
¥128.07
Free cash flow
¥58.90B
Net profit margin
15.35%
Gross margin
73.91%
EBITDA
¥114.90B
Revenue growth
0.26%
Similar securities
This is not an investment recommendation
How to buy Kyowa Kirin from India
Indian residents can buy Kyowa Kirin shares through Paasa in four steps. Funds leave India under the RBI's Liberalised Remittance Scheme and the shares are held in your own name with Interactive Brokers.
Open a Paasa account
Complete digital KYC with your PAN, Aadhaar and address proof. Your brokerage account is opened in your own name with Interactive Brokers.
Add funds under LRS
Transfer INR from your Indian bank account. Your bank reports the remittance under the RBI's Liberalised Remittance Scheme and converts it to US dollars and then to JPY.
Search for Kyowa Kirin and place an order
Find Kyowa Kirin by name or by its ticker, 4151, and choose an order type. The Tokyo Stock Exchange typically trades in units of 100 shares. Kyowa Kirin trades 5:30 am – 12:00 pm IST; orders can only execute during that window.
Track holdings and download tax reports
Follow your Kyowa Kirin position in JPY and INR, and use Paasa's capital-gains and dividend statements when you file your Indian return.
Read the full guide: how to invest in Kyowa Kirin from India
Trading and taxes when buying Kyowa Kirin from India
Trading and limits
- Trading hours
- 9:00 am – 3:30 pm JST
- LRS limit
- $250,000Per financial year, under the RBI's Liberalised Remittance Scheme.
Tax for Indian residents
- TCS on remittance
- 20%Collected by your bank on LRS remittances above ₹10 lakh in a financial year. The TCS is adjustable against your income-tax liability.Adjusting TCS against your tax
- Capital gains in India
- 12.5% or slab rateGains on shares held for more than 24 months are long-term and taxed at 12.5%. Gains on shares held for 24 months or less are short-term and taxed at your income-tax slab rate.Capital gains explained
- Dividends
- Slab rateDividends are taxed at your slab rate in India. Japan withholds a preferential 10% on dividends for Indian residents under the India–Japan DTAA rather than the higher domestic rate, and the tax withheld can be claimed as a foreign tax credit in India. Kyowa Kirin’s current yield is 2.96%.Dividend tax explained
- Estate or inheritance tax
- May applyJapan levies inheritance tax on Japan-located assets such as direct stocks, with an exemption of ¥30 million plus ¥6 million per statutory heir.Estate tax explained
Custody. Shares are held in your own name at Interactive Brokers, segregated from Paasa's own assets.
FAQs
Can Indian residents buy Kyowa Kirin stock?
Yes. Kyowa Kirin (4151) has been listed on the Tokyo Stock Exchange since 1949, in the Medical - Pharmaceuticals industry, and Indian residents can buy it through Paasa. You fund the account from your Indian bank under the RBI's Liberalised Remittance Scheme and the money is converted to US dollars and then to JPY. Shares are held in your own name at Interactive Brokers, segregated from Paasa's own assets.
How much does one Kyowa Kirin share cost in rupees?
One Kyowa Kirin share is ¥2,267.00 — about ₹1,380 at a JPY/INR rate of 0.6089 on 25 Sep 2026. Both the Kyowa Kirin price and the rupee rate move during the day, so the rupee cost changes with them.
What are the LRS and TCS rules for buying Kyowa Kirin from India?
Remit up to $250,000 per financial year under the RBI's Liberalised Remittance Scheme (LRS). Banks collect 20% tax at source on LRS remittances above ₹10 lakh in a financial year; the TCS is adjustable against your income-tax liability. FX and the LRS declaration are handled by your bank when you fund your account.
What is the minimum I can buy of Kyowa Kirin?
The Tokyo Stock Exchange typically trades in units of 100 shares.
How are gains on Kyowa Kirin shares taxed in India?
Japan generally does not levy capital gains tax on non-resident individual investors, so the tax is an India-side one. Gains on shares held for more than 24 months are long-term and taxed at 12.5%. Gains on shares held for 24 months or less are short-term and taxed at your income-tax slab rate. The gain is computed in rupees using the JPY/INR rate on the purchase and the sale date, so the rupee move counts alongside the Kyowa Kirin price. Paasa issues a capital-gains statement for your return.
Does Kyowa Kirin pay a dividend, and how is it taxed in India?
Yes. Kyowa Kirin pays a dividend and the current yield is 2.96%; the last declared dividend was ¥67.00 per share, about ₹40.79. Dividends are taxed at your slab rate in India. Japan withholds a preferential 10% on dividends for Indian residents under the India–Japan DTAA rather than the higher domestic rate, and the tax withheld can be claimed as a foreign tax credit in India. Paasa's dividend report lists the gross dividend and any tax withheld for each payment.
When can I trade Kyowa Kirin from India?
The Tokyo Stock Exchange trades 5:30 am – 12:00 pm IST in Indian time. It also halts for lunch, 8:00 am – 9:00 am IST. Orders can only execute during that window.
Is there estate or inheritance tax on Kyowa Kirin shares held from India?
Japan levies inheritance tax on Japan-located assets such as direct stocks, with an exemption of ¥30 million plus ¥6 million per statutory heir. It applies to your overall holdings in that jurisdiction rather than to any one position.
Do I have to declare Kyowa Kirin shares in my Indian tax return?
Yes. Foreign shares held on 31 March must be reported in Schedule FA of your Indian income-tax return. Paasa gives you a Schedule FA-ready statement listing your Kyowa Kirin holding, its cost and its closing value.
How do I sell Kyowa Kirin and bring the money back to India?
You sell during market hours (5:30 am – 12:00 pm IST) and the proceeds settle in JPY in your Paasa account. From there you can hold the balance, reinvest, or repatriate. Funds can be withdrawn in any currency to any bank account in your own name. Whether the sale is short- or long-term is decided by the 24-month holding period.